Skip to main content
Clinical Trials/NCT04785404
NCT04785404CompletedNot Applicable

Primary Versus Secondary Closure of Stoma-Reversal Skin Wound: Randomized Controlled Trial

Ayub Teaching Hospital1 site in 1 country50 target enrollmentStarted: January 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
surgical site infection

Study Overview

Brief Summary

to compare infection rate stoma reversal skin wound after primary or secondary closure

Detailed Description

There will be two groups. In group A, skin will be stitched with prolene while in group B skin will be left open to follow up till 1 month and wound observed for infection according to CDC guidelines.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •. All patients who undergo ileostomy or colostomy reversal will be included

Exclusion Criteria

  • •included patients with reversal of stoma through laparatomy, post-operative anastomotic leak and co-morbidities like diabetes, Chronic liver disease, chronic kidney disease etc

Arms & Interventions

primary skin closure

Experimental

in this group, skin wound will be primarily closed

Intervention: primary skin closure (Procedure)

secondary skin closure

No Intervention

skin will be left open to heal by secondary intention

Outcomes

Primary Outcomes

surgical site infection

Time Frame: 30 days

skin wound infection at surgical site will be observed on CDC guidelines

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials